Richard Cook

Corporate Officer/Principal at University of British Columbia

Consumer Services

Commercial Services

Health Technology

Profile

Richard Cook is an Associate Professor at the University of British Columbia, where he has been working since 2013.
Prior to his current position, he worked as the Chief Medical Officer at Avagenesis Corp.
and Enlighta, Inc. Cook holds a doctorate degree from the University of Alberta and a graduate degree from the University of British Columbia.

Richard Cook active positions

Companies	Position	Start
University of British Columbia	Corporate Officer/Principal	31/12/2012

All active positions of Richard Cook

Former positions of Richard Cook

Companies	Position	End
ENLIGHTA INC.	Chief Tech/Sci/R&D Officer	-
Avagenesis Corp. Avagenesis Corp. Miscellaneous Commercial ServicesCommercial Services Avagenesis Corp. engages in the development and commercialization of licensed, patent-pending and patented, automated bioprocessing, and cell-isolation technology for the isolation of regenerative cells from human adipose tissues for use in research and for cosmetic and aesthetic medicine. It uses a proprietary cellular bioprocessing technology. The company was founded on December 10, 2010 and is headquartered in Richmond, Canada.	Chief Tech/Sci/R&D Officer	-

See the detail of Richard Cook's experience

Training of Richard Cook

University of Alberta	Doctorate Degree
University of British Columbia	Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Richard Cook's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
ENLIGHTA INC.	Health Technology

Private companies	1
Avagenesis Corp. Avagenesis Corp. Miscellaneous Commercial ServicesCommercial Services Avagenesis Corp. engages in the development and commercialization of licensed, patent-pending and patented, automated bioprocessing, and cell-isolation technology for the isolation of regenerative cells from human adipose tissues for use in research and for cosmetic and aesthetic medicine. It uses a proprietary cellular bioprocessing technology. The company was founded on December 10, 2010 and is headquartered in Richmond, Canada.	Commercial Services